310034
炭酸カルシウム
powder, ≤50 μm particle size, 98%
別名:
Calcite, Calcium monocarbonate, Monocalcium carbonate
ログインで組織・契約価格をご覧ください。
サイズを選択してください
この商品について
化学式:
CaCO3
CAS番号:
分子量:
100.09
UNSPSC Code:
12352302
NACRES:
NA.23
PubChem Substance ID:
EC Number:
207-439-9
Beilstein/REAXYS Number:
8008338
MDL number:
製品名
炭酸カルシウム, powder, ≤50 μm particle size, 98%
InChI key
VTYYLEPIZMXCLO-UHFFFAOYSA-L
InChI
1S/CH2O3.Ca/c2-1(3)4;/h(H2,2,3,4);/q;+2/p-2
SMILES string
[Ca++].[O-]C([O-])=O
assay
98%
form
powder
reaction suitability
core: calcium
particle size
≤50 μm
solubility
H2O: insoluble
density
2.93 g/mL at 25 °C (lit.)
Quality Level
類似した製品をお探しですか？ 訪問 製品比較ガイド
関連するカテゴリー
General description
炭酸カルシウム（CaCO3）は、チョーク、石灰石および大理石に含まれる自然に生じる物質です。炭酸カルシウムは炭素、酸素、カルシウムという3つの元素で構成されます。二酸化炭素を消和または燃焼した生石灰と反応させて生成します。工業、食品から農業まで広範囲の用途で使用できます。
保管分類
13 - Non Combustible Solids
wgk
nwg
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
dust mask type N95 (US), Eyeshields, Gloves
Calcium carbonate: from the Cretaceous period into the 21st century (2001)
Fei Wang et al.
Environmental science & technology, 49(9), 5672-5680 (2015-04-09)
The mineralization of perfluorinated alkyl substances (PFASs) by calcium compounds during the waste thermal treatment was systemically studied. Different calcium compounds showed different mineralization efficiencies of PFASs during the thermal process, owing to the different reaction mechanisms. Calcium hydroxide was
M Azizur Rahman et al.
PloS one, 8(3), e58781-e58781 (2013-03-26)
An organic matrix consisting of a protein-polysaccharide complex is generally accepted as an important medium for the calcification process. While the role this "calcified organic matrix" plays in the calcification process has long been appreciated, the complex mixture of proteins
Jane A Cauley et al.
Journal of women's health (2002), 22(11), 915-929 (2013-10-18)
Clinical outcomes of the Women's Health Initiative (WHI) calcium plus vitamin D supplementation trial have been reported during 7.0 years of active intervention. We now report outcomes 4.9 years after the intervention stopped and cumulative findings. Postmenopausal women (N=36,282) were
Sophie A Jamal et al.
Lancet (London, England), 382(9900), 1268-1277 (2013-07-23)
Phosphate binders (calcium-based and calcium-free) are recommended to lower serum phosphate and prevent hyperphosphataemia in patients with chronic kidney disease, but their effects on mortality and cardiovascular outcomes are unknown. We aimed to update our meta-analysis on the effect of
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら（テクニカルサービス）